10.4239/wjd.v10.i1.1 5
This growth was accelerated in 2021 when the FDA approved semaglutide, a Novo Nordisk product under the brand name of Wegovy, for chronic weight management
What Patients Should Ask Before Starting Treatment Before starting semaglutide, tirzepatide, or any medical weight loss medication, patients should ask whether they are medically appropriate for the medication, which option fits their health history, what side effects to watch for, what dose strategy will be used, what labs should be checked, how blood sugar, liver, kidney, and cardiovascular risk will be monitored, how muscle mass will be protected, what nutrition changes are needed, what happens if they hit a plateau, and whether the medication is coming from a legitimate, licensed pharmacy
Harrist A, Beech RD, King SL, Zanardi A, Cleary MA, Caldarone BJ, et al
the athletic population or b)
Understanding these distinctions is essential for appropriate prescribing and patient counseling